T1	CHEM 24 31	papaína
#1	AnnotatorNotes T1	C0030346; papain; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T2	PROC 38 49	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 53 68	úlceras venosas
#3	AnnotatorNotes T3	C0042344; Varicose Ulcer; Disease or Syndrome
T4	PROC 70 94	ensayo clínico aleatorio
#4	AnnotatorNotes T4	C0206034; Clinical Trials, Randomized; Research Activity
T5	PROC 107 129	evaluar la efectividad
T6	CHEM 141 148	papaína
#5	AnnotatorNotes T6	C0030346; papain; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T7	CHEM 178 198	carboximetilcelulosa
#6	AnnotatorNotes T7	C0007068; carboxymethylcellulose; Organic Chemical · Pharmacologic Substance
T8	PROC 210 221	tratamiento
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	DISO 239 254	úlceras venosas
#8	AnnotatorNotes T9	C0042344; Varicose Ulcer; Disease or Syndrome
T10	DISO 1104 1124	tejido desvitalizado
T11	PROC 326 337	seguimiento
#9	AnnotatorNotes T11	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T12	DISO 414 429	úlceras venosas
#10	AnnotatorNotes T12	C0042344; Varicose Ulcer; Disease or Syndrome
T13	PROC 443 454	experimento
#11	AnnotatorNotes T13	C0678323; experimentation; Research Activity | C0681814; research study; Research Activity
T14	CHEM 480 487	papaína
#12	AnnotatorNotes T14	C0030346; papain; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T15	CHEM 527 547	carboximetilcelulosa
#13	AnnotatorNotes T15	C0007068; carboxymethylcellulose; Organic Chemical · Pharmacologic Substance
T16	PROC 577 588	experimento
#14	AnnotatorNotes T16	C0678323; experimentation; Research Activity | C0681814; research study; Research Activity
T17	DISO 640 648	lesiones
#15	AnnotatorNotes T17	C0221198; Lesion; Finding
T18	PROC 709 720	tratamiento
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	DISO 730 750	úlceras cicatrizadas
T20	ANAT 789 812	tejido de epitelización
T21	DISO 832 840	lesiones
#17	AnnotatorNotes T21	C0221198; Lesion; Finding
T22	CHEM 866 873	papaína
#18	AnnotatorNotes T22	C0030346; papain; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T23	DISO 960 968	lesiones
#19	AnnotatorNotes T23	C0221198; Lesion; Finding
T24	CHEM 1010 1030	carboximetilcelulosa
#20	AnnotatorNotes T24	C0007068; carboxymethylcellulose; Organic Chemical · Pharmacologic Substance
T25	ANAT 1091 1098	exudado
#21	AnnotatorNotes T25	C0015388; Exudate; Body Substance
T26	ANAT 1104 1110	tejido
#22	AnnotatorNotes T26	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T27	PROC 1155 1178	estudios multicéntricos
#23	AnnotatorNotes T27	C1096776; Multicenter Study; Research Activity
T28	CHEM 1221 1228	papaína
#24	AnnotatorNotes T28	C0030346; papain; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Enzyme
T29	PROC 1184 1209	evidenciar la efectividad
T30	DISO 1257 1272	úlceras venosas
#25	AnnotatorNotes T30	C0042344; Varicose Ulcer; Disease or Syndrome
T31	ANAT 61 68	venosas
#26	AnnotatorNotes T31	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T32	ANAT 247 254	venosas
#27	AnnotatorNotes T32	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T33	PROC 275 310	ensayo clínico controlado aleatorio
#28	AnnotatorNotes T33	C0206035; Controlled Clinical Trials, Randomized; Research Activity
T34	ANAT 422 429	venosas
#29	AnnotatorNotes T34	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T35	ANAT 1265 1272	venosas
#30	AnnotatorNotes T35	C0042449; Veins; Body Part, Organ, or Organ Component | C1278960; Entire vein; Body Part, Organ, or Organ Component
T36	Form 17 20	gel
#31	AnnotatorNotes T36	C0017243; Gel; Biomedical or Dental Material
T37	Form 134 137	gel
#32	AnnotatorNotes T37	C0017243; Gel; Biomedical or Dental Material
T38	Dose 149 153	a 2%
T39	Form 171 174	gel
#33	AnnotatorNotes T39	C0017243; Gel; Biomedical or Dental Material
T40	Dose 199 203	a 2%
T41	LIVB 225 234	pacientes
#34	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Duration 255 263	crónicas
#35	AnnotatorNotes T42	C0205191; chronic; Temporal Concept
T43	Duration 341 351	12 semanas
T44	Form 473 476	gel
#36	AnnotatorNotes T44	C0017243; Gel; Biomedical or Dental Material
T45	Dose 488 492	a 2%
T46	LIVB 502 515	grupo control
#37	AnnotatorNotes T46	C0009932; Control Groups; Group
T47	Form 520 523	gel
#38	AnnotatorNotes T47	C0017243; Gel; Biomedical or Dental Material
T48	Dose 548 552	a 2%
T49	Duration 678 705	entre la 5ª y la 12ª semana
T50	PHYS 799 812	epitelización
#39	AnnotatorNotes T50	C0334029; Epithelialization; Organ or Tissue Function
T51	Form 859 862	gel
#40	AnnotatorNotes T51	C0017243; Gel; Biomedical or Dental Material
T52	Dose 874 878	a 2%
T53	Form 1003 1006	gel
#41	AnnotatorNotes T53	C0017243; Gel; Biomedical or Dental Material
T54	Dose 1031 1035	a 2%
T56	Form 1214 1217	gel
#42	AnnotatorNotes T56	C0017243; Gel; Biomedical or Dental Material
T57	Dose 1229 1233	a 2%
T58	PHYS 738 750	cicatrizadas
#43	AnnotatorNotes T58	C0043240; Wound Healing; Organism Function
T60	PHYS 1111 1124	desvitalizado
#44	AnnotatorNotes T60	C0027540; Necrosis; Organ or Tissue Function
T61	PHYS 1240 1253	cicatrización
#45	AnnotatorNotes T61	C0043240; Wound Healing; Organism Function
T62	LIVB 385 396	voluntarios
#46	AnnotatorNotes T62	C0020155; Human Volunteers; Population Group
T63	LIVB 571 588	grupo experimento
#47	AnnotatorNotes T63	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T59	LIVB 437 454	grupo experimento
#48	AnnotatorNotes T59	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
R1	Has_Drug_Form Arg1:T1 Arg2:T36	
R2	Used_for Arg1:T1 Arg2:T2	
R3	Location_of Arg1:T31 Arg2:T3	
R4	Has_Drug_Form Arg1:T6 Arg2:T37	
R5	Has_Dose_or_Strength Arg1:T6 Arg2:T38	
R6	Has_Drug_Form Arg1:T7 Arg2:T39	
R7	Has_Dose_or_Strength Arg1:T7 Arg2:T40	
R8	Used_for Arg1:T7 Arg2:T8	
R9	Experiences Arg1:T41 Arg2:T7	
R10	Experiences Arg1:T41 Arg2:T6	
R11	Experiences Arg1:T41 Arg2:T9	
R12	Location_of Arg1:T32 Arg2:T9	
R13	Has_Duration_or_Interval Arg1:T9 Arg2:T42	
R14	Has_Duration_or_Interval Arg1:T11 Arg2:T43	
R15	Experiences Arg1:T62 Arg2:T12	
R16	Location_of Arg1:T34 Arg2:T12	
R17	Experiences Arg1:T59 Arg2:T13	
R18	Experiences Arg1:T59 Arg2:T14	
R19	Experiences Arg1:T46 Arg2:T15	
R20	Has_Dose_or_Strength Arg1:T15 Arg2:T48	
R21	Has_Drug_Form Arg1:T15 Arg2:T47	
R22	Has_Dose_or_Strength Arg1:T14 Arg2:T45	
R23	Has_Drug_Form Arg1:T14 Arg2:T44	
R24	Experiences Arg1:T63 Arg2:T16	
T55	CONC 598 607	reducción
#49	AnnotatorNotes T55	C0547047; Decrease; Quantitative Concept
R26	Has_Duration_or_Interval Arg1:T55 Arg2:T49	
R27	Has_Duration_or_Interval Arg1:T18 Arg2:T49	
R30	Location_of Arg1:T20 Arg2:T50	
R31	Location_of Arg1:T20 Arg2:T21	
T65	CONC 628 648	área de las lesiones
R32	Experiences Arg1:T63 Arg2:T17	
R33	Experiences Arg1:T63 Arg2:T18	
R34	Experiences Arg1:T63 Arg2:T19	
R35	Experiences Arg1:T63 Arg2:T21	
R36	Has_Drug_Form Arg1:T22 Arg2:T51	
R37	Has_Dose_or_Strength Arg1:T22 Arg2:T52	
R40	Has_Dose_or_Strength Arg1:T24 Arg2:T54	
R41	Has_Drug_Form Arg1:T24 Arg2:T53	
R44	Location_of Arg1:T26 Arg2:T10	
R46	Has_Drug_Form Arg1:T28 Arg2:T56	
R47	Has_Dose_or_Strength Arg1:T28 Arg2:T57	
R48	Before Arg1:T28 Arg2:T61	
R49	Location_of Arg1:T35 Arg2:T30	
R50	Overlap Arg1:T61 Arg2:T30	
R29	Used_for Arg1:T6 Arg2:T8	
R25	Experiences Arg1:T63 Arg2:T58	
R28	Experiences Arg1:T63 Arg2:T50	
T64	CONC 948 968	área de las lesiones
T66	CONC 932 941	reducción
#50	AnnotatorNotes T66	C0547047; Decrease; Quantitative Concept
R38	Before Arg1:T18 Arg2:T58	
#51	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
#52	AnnotatorNotes T20	C0014609; Epithelium; Tissue
#53	AnnotatorNotes T19	C1265810; Healed ulcer; Pathologic Function
A1	Experiencer T41 Patient
A2	Experiencer T62 Patient
A3	Experiencer T59 Patient
A4	Experiencer T46 Patient
A5	Experiencer T63 Patient
